MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
3.005
-0.045
-1.48%
Opening 11:22 12/11 EST
OPEN
3.050
PREV CLOSE
3.050
HIGH
3.050
LOW
2.970
VOLUME
5.53K
TURNOVER
--
52 WEEK HIGH
23.80
52 WEEK LOW
2.560
MARKET CAP
4.53M
P/E (TTM)
-0.1244
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GLMD last week (1202-1206)?
Weekly Report · 2d ago
Weekly Report: what happened at GLMD last week (1125-1129)?
Weekly Report · 12/02 10:34
Weekly Report: what happened at GLMD last week (1118-1122)?
Weekly Report · 11/25 10:29
Weekly Report: what happened at GLMD last week (1111-1115)?
Weekly Report · 11/18 10:27
Galmed Pharmaceuticals: Q3 Earnings Snapshot
Barchart · 11/15 07:28
Galmed Pharmaceuticals Embraces Market with New Sales Agreement
TipRanks · 11/14 22:47
GALMED PHARMACEUTICALS LTD FILES FOR MIXED SHELF OF UP TO $200 MLN - SEC FILING
Reuters · 11/14 22:12
Galmed Pharmaceuticals Strengthens Financial Position Amid Losses
TipRanks · 11/14 21:29
More
About GLMD
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Webull offers Galmed Pharmaceuticals Ltd stock information, including NASDAQ: GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.